Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Obesity, Morbid × Leuprolide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 146 Breast Neoplasms 20 Neoplasms 9 Leiomyoma 8 Polycystic Ovary Syndrome 5 Adenocarcinoma 3 Salivary Gland Neoplasms 2 Rare Diseases 2 Prostate Adenocarcinoma 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms, Male 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urogenital Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Skin Diseases 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasm Duct 1 Respiratory Tract Diseases 1 Recurrence 1 Puberty, Precocious 1 Prostatic Diseases 1 Primary Dysautonomias 1 Premenopausal Breast Cancer 1 PSA Level Greater Than Two 1 Obesity, Morbid 1

Interventions

Robotic Surgical Procedures 2 Metformin 1 Leuprolide 1 Laparoscopy 1 Hepatectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04331717 2022-05-02

BASH-PC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Obesity, Morbid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡